Evidence Hub

Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial

Weaver AA, Greene KA, Leng X, Lenchik L, Lyles MF, Nicklas BJ, Baker AM, Helgason B et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026

187 participants · 3 citations

Abstract

Weight loss in older age can cause bone loss. In older adults with overweight/obesity in a weight loss trial, 6-month hip bone strength increased with higher protein intake versus controls consuming the Recommended Dietary Allowance. However, greater weight loss was associated with greater 18-month hip bone mineral density loss.

Purpose: Weight loss (WL) to treat obesity in older age can exacerbate bone loss.

Methods: This trial assessed the effects of higher protein intake on hip bone outcomes in 187 older adults with overweight/obesity participating in 6 months of active WL (caloric restriction + aerobic exercise) followed by a 12-month maintenance phase. Participants were randomized to either the Recommended Dietary Allowance for protein intake of 0.8 g protein/kg body weight/day (RecProt) or higher protein intake of 1.2 g protein/kg/day for the 6-month WL period only (6-mo HiProt) or the full 18-month period (18-mo HiProt). CT scans at baseline, 6 months, and 18 months were analyzed for hip volumetric bone mineral density (vBMD) and cortical thickness; bone strength was assessed via finite element modeling of a sideways fall. Areal (a)BMD was measured with hip dual-energy X-ray absorptiometry. Analyses examined 6-month and 18-month bone changes using analysis of covariance, and Spearman's correlations of WL vs. bone changes.

Results: Greater WL was associated with greater gains in hip bone strength (p = 0.007) at 6 months, but greater trabecular vBMD loss at 18 months (p…

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 187 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free